Home>Topics>Companies>Watson Pharmaceuticals

Watson Pharmaceuticals WPI

  1. All
  2. Commentary
  3. Stock Reports
  4. Headlines
    1. New drugs help Actavis beat profit estimates

      Headlines

      Thu, 2 May 2013

      May 2 (Reuters) - Generic drugmaker Actavis Inc, formerly known as Watson Pharmaceuticals , reported an adjusted quarterly profit that beat market estimates, helped by new products, and the company raised its earnings forecast for the full year.

    2. Stockton is Bankrupt: Now What?

      Headlines

      Thu, 11 Apr 2013

      Report: Merck Analyst Report: Mylan Technologies MYL Analyst Report: Teva Pharmaceuticals Analyst Report: Watson Pharmaceuticals WPI Rethinking Title Insurer Moat, Risk Ratings Analyst Jim Ryan reduced the moat rating and increased the risk

    3. Actavis Previews Financial Results and Highlights Plan for Future Growth

      Commentary

      Fri, 25 Jan 2013

      Now trading under its official new name, Actavis ACT (formerly Watson Pharmaceuticals ) highlighted its long-term growth strategy and presented expectations for the current quarter and upcoming 2013 results at its

    4. Actavis, formerly Watson, sees 2013 profit growth

      Headlines

      Fri, 25 Jan 2013

      Jan 25 (Reuters) - Actavis Inc, the generic drugmaker previously known as Watson Pharmaceuticals , said on Friday that it expected earnings to rise at least 30 percent in 2013 as it expands globally, but its outlook still came in short of analysts' expectations.

    5. Watson Pharmaceuticals ( WPI ) announces plans to restructure operations at its Corona, California facility. As such, manufacturing and related support functions at the site will be reduced and ...

      Headlines

      Tue, 8 Jan 2013

      Watson Pharmaceuticals ( WPI ) announces plans to restructure operations at its Corona, California facility. As such, manufacturing and related support functions

    6. Watson seeks approval of generic version of cancer drug Velcade

      Headlines

      Fri, 28 Dec 2012

      Dec 28 (Reuters) - Watson Pharmaceuticals Inc said on Friday it has applied for U.S. approval to market a generic version of Velcade, a treatment for multiple myeloma made by Takeda Pharmaceutical Co.

    7. Columbia Laboratories Inc.: Recent Events Lead To An Opportune Entry Point

      Headlines

      Fri, 21 Dec 2012

      Columbia Laboratories Inc.( CBRX ) confirmed that the U.S. Food and Drug Administration (FDA) had denied Watson Pharmaceuticals , Inc .'s ( WPI ) Formal Dispute Resolution Request (FDRR) related to its New Drug Application (NDA 22-139

    8. The Generics Empire Of Watson Pharma Soon To Be Named Actavis

      Headlines

      Tue, 6 Nov 2012

      By Peter Geschek : In 2013 Watson Pharmaceuticals ( WPI ) is changing its name to Actavis because the brand is more recognizable globally and to avoid confusion with other businesses

    9. Watson Pharmaceuticals Management Discusses Q3 2012 Results - Earnings Call Transcript

      Headlines

      Thu, 1 Nov 2012

      Watson Pharmaceuticals ( WPI ) Q3 2012 Earnings Call November 01, 2012 8:30 am ET Executives Lisa M. Defrancesco - Former Vice President of Global Investor

    10. Watson Pharmaceutical: Superb Quality Of Earnings Is Catalyst To Push Shares Higher

      Headlines

      Wed, 31 Oct 2012

      By Jason Merriam : Watson Pharmaceuticals ( WPI ) is a leading integrated global pharmaceutical company engaged in the development, manufacturing, marketing, sale, and distribution

    « Prev12345Next »
    Content Partners